TY - JOUR PY - 2015// TI - Impact of depression on progression of impairment and disability in early Parkinson's disease JO - Movement disorders clinical practice A1 - Bega, Danny A1 - Luo, Sheng A1 - Fernandez, Hubert A1 - Chou, Kelvin A1 - Aminoff, Michael A1 - Parashos, Sotirios A1 - Walker, Harrison A1 - Russell, David S. A1 - Christine, Chadwick W. A1 - Dhall, Rohit A1 - Singer, Carlos A1 - Bodis-Wollner, Ivan A1 - Hamill, Robert A1 - Truong, Daniel A1 - Mari, Zoltan A1 - Glazmann, Sofya A1 - Huang, Meilin A1 - Houston, Emily A1 - Simuni, Tanya SP - 371 EP - 378 VL - 2 IS - 4 N2 - BACKGROUND: Depression is one of the most common nonmotor symptoms associated with Parkinson's disease (PD), yet the impact of depression on progression of disease is unclear.

OBJECTIVE: The aim of this study was to prospectively characterize the relationship between depressive symptoms and measures of disease progression in a large sample of patients with early, medically treated PD.

METHODS: Baseline and longitudinal Beck Depression Inventory (BDI) scores from participants in the NINDS Exploratory Trials in PD Long Term Study 1 were correlated with changes in multiple measures of disease severity over 5 years. Multivariate analysis of predictors of change in BDI was performed.

RESULTS: Of 1,741 participants, 746 completed 5-year assessments and were included. Mean age was 62.00 years (standard deviation [SD]: 9.22) and mean disease duration was 1.69 years (SD, 1.16). Mean BDI score was 6.24 (SD, 5.02) at baseline and 8.57 (SD, 6.60) at 5 years. Baseline BDI score was strongly associated with rate of change in all examined measures of disease severity. In multivariate analysis, BDI 5-year change was associated with change in UPDRS Part I (excluding depression item; P < 0.01), 33-item Parkinson's Disease Questionnaire (P < 0.01), EuroQOL Five Dimensional Questionnaire (P = 0.02), and Total Functional Capacity (P < 0.01), but was not associated with motor or cognitive measures. This model explained 68.8% of the variance 5-year change of the BDI score.

CONCLUSIONS: Worse baseline BDI scores are associated with a decline in multiple measures of disease severity in PD. Worsening of BDI at 5 years was associated with worsening in UPDRS Part I and quality-of-life measures, but not with motor or cognitive measures.

Language: en

LA - en SN - 2330-1619 UR - http://dx.doi.org/10.1002/mdc3.12205 ID - ref1 ER -